These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 17652740

  • 1. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis.
    Milikan JC, Kinchington PR, Baarsma GS, Kuijpers RW, Osterhaus AD, Verjans GM.
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3689-97. PubMed ID: 17652740
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the varicella zoster virus (VZV)-specific intra-ocular T-cell response in patients with VZV-induced uveitis.
    Milikan JC, Kuijpers RW, Baarsma GS, Osterhaus AD, Verjans GM.
    Exp Eye Res; 2006 Jul; 83(1):69-75. PubMed ID: 16530754
    [Abstract] [Full Text] [Related]

  • 3. Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells.
    Milikan JC, Baarsma GS, Kuijpers RW, Osterhaus AD, Verjans GM.
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):743-51. PubMed ID: 18936136
    [Abstract] [Full Text] [Related]

  • 4. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.
    Ouwendijk WJ, Geluk A, Smits SL, Getu S, Osterhaus AD, Verjans GM.
    J Immunol; 2014 Apr 15; 192(8):3730-9. PubMed ID: 24623134
    [Abstract] [Full Text] [Related]

  • 5. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J.
    J Immunol; 1991 Jan 01; 146(1):257-64. PubMed ID: 1670603
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS, Smith S, Hunter E, Arvin AM.
    J Immunol; 1989 Jan 15; 142(2):636-41. PubMed ID: 2536059
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
    Sadzot-Delvaux C, Kinchington PR, Debrus S, Rentier B, Arvin AM.
    J Immunol; 1997 Sep 15; 159(6):2802-6. PubMed ID: 9300702
    [Abstract] [Full Text] [Related]

  • 10. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids.
    Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T.
    Invest Ophthalmol Vis Sci; 1997 Mar 15; 38(3):676-89. PubMed ID: 9071222
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
    Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ.
    J Infect Dis; 2003 Nov 01; 188(9):1336-44. PubMed ID: 14593591
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
    Jenkins DE, Yasukawa LL, Bergen R, Benike C, Engleman EG, Arvin AM.
    J Immunol; 1999 Jan 01; 162(1):560-7. PubMed ID: 9886433
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of varicella zoster virus load in the aqueous humor with clinical manifestations of anterior uveitis in herpes zoster ophthalmicus and zoster sine herpete.
    Kido S, Sugita S, Horie S, Miyanaga M, Miyata K, Shimizu N, Morio T, Mochizuki M.
    Br J Ophthalmol; 2008 Apr 01; 92(4):505-8. PubMed ID: 18245272
    [Abstract] [Full Text] [Related]

  • 18. Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus.
    Vossen MT, Gent MR, Weel JF, de Jong MD, van Lier RA, Kuijpers TW.
    J Infect Dis; 2004 Jul 01; 190(1):72-82. PubMed ID: 15195245
    [Abstract] [Full Text] [Related]

  • 19. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
    Schub D, Janssen E, Leyking S, Sester U, Assmann G, Hennes P, Smola S, Vogt T, Rohrer T, Sester M, Schmidt T.
    J Infect Dis; 2015 Feb 15; 211(4):600-12. PubMed ID: 25180236
    [Abstract] [Full Text] [Related]

  • 20. Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults.
    De Castro N, Carmagnat M, Kernéis S, Scieux C, Rabian C, Molina JM.
    AIDS Res Hum Retroviruses; 2011 Oct 15; 27(10):1089-97. PubMed ID: 21417759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.